A landmark £42 million trial aimed at revolutionising prostate cancer screening has officially begun in the UK, with the first eligible men now invited to participate. Health Secretary Wes Streeting ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Prostate health is something every man should be aware of yet few people want to discuss. An enlarged prostate – called benign prostatic hyperplasia (BPH) – can lead to the need for surgery, which ...
The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation. The £42m trial is being co-led by UCL, ...
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one agent shown to shrink tumors in patients whose disease had resisted every ...
The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...
A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans ...
The UCLA trial is currently enrolling patients. Clinical trial compares two targeted radiation therapies for recurrent prostate cancer. New AI tool, ProCUSNet, detects prostate cancer more accurately ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results